GSK-1322322

CAS No. 1152107-25-9

GSK-1322322( Lanopepden | GSK-322 )

Catalog No. M10536 CAS No. 1152107-25-9

A novel antibacterial agent that targets bacterial peptide deformylase; demonstrates in vitro activity against MDR respiratory and skin infection pathogens.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 901 In Stock
10MG 1207 In Stock
25MG 1796 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    GSK-1322322
  • Note
    Research use only, not for human use.
  • Brief Description
    A novel antibacterial agent that targets bacterial peptide deformylase; demonstrates in vitro activity against MDR respiratory and skin infection pathogens.
  • Description
    A novel antibacterial agent that targets bacterial peptide deformylase; demonstrates in vitro activity against MDR respiratory and skin infection pathogens, including MDR Streptococcus pneumoniae and MRSA; inhibits S. pneumoniae ATCC 49619 with MIC of 0.12-0.5 ug/mL.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Lanopepden | GSK-322
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    Antibacterial
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    1152107-25-9
  • Formula Weight
    479.56
  • Molecular Formula
    C22H34FN7O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 30 mg/mL (62.56 mM)
  • SMILES
    CC1=NC(=C(C(=N1)N2CCN3CCOCC3C2)F)NNC(=O)C(CC4CCCC4)CN(C=O)O
  • Chemical Name
    N-((R)-2-(cyclopentylmethyl)-3-(2-(5-fluoro-6-((S)-hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl)-2-methylpyrimidin-4-yl)hydrazinyl)-3-oxopropyl)-N-hydroxyformamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ross JE, et al. J Clin Microbiol. 2011 Nov;49(11):3928-30. 2. Arat S, et al. Antimicrob Agents Chemother. 2015 Feb;59(2):1182-92. 3. O'Dwyer K, et al. Antimicrob Agents Chemother. 2013 May;57(5):2333-42.
molnova catalog
related products
  • JCP251

    JCP251 is a selective small molecule inhibitor of S. aureus serine hydrolase FphB, effectively reduces infectivity in vivo.

  • Cefoperazone sodium

    Cefoperazone sodium salt is a cephalosporin antibiotic for inhibition of rMrp2-mediated [3H]E217βG uptake with IC50 of 199 μM.

  • LpxH-IN-AZ1

    LpxH-IN-AZ1 is a potent inhibitor of the UDP-2,3-diacylglucosamine pyrophosphate hydrolase, LpxH, and sulfonylpiperazine compounds.